Ireland· IE-PA-PA0540/141/001
Calcium Resonium 99.934% Powder for oral or rectal suspension
A polystyrene sulfonate product containing calcium polystyrene sulphonate, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Polystyrene sulfonate is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AE01 (polystyrene sulfonate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Polystyrene sulfonate · ATC V03AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of polystyrene sulfonate costs, country by country.
Normalised to the WHO defined daily dose (45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Polystyrene sulfonate · price per daily dose (45 g)
USD · FX 28 Sept 2026
- CZ Czechia$0.0074
The record
At a glance
HPRA (Ireland)- Active substance
- Calcium polystyrene sulphonate
- Manufacturer
- Sanofi-Aventis Ireland Limited T/A SANOFI
- Country
- Ireland (IE)
- ATC code
- V03AE01
- ATC class
- Polystyrene sulfonate
- Defined daily dose
- 45 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0540/141/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Polystyrene sulfonate in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCalcium polystyrene sulfonate 30g/100ml enemaSpecial Order
- Japanポリスチレンスルホン酸カルシウム東洋製薬化成
- FinlandSorbisteritFresenius Medical Care Nephrologica Deutschland GmbH
- BelgiumKayexalate Calcium 14.99 gSanofi Belgium
- GermanyElutit-CalciumAgraria Pharma Gmbh
- FranceRESIKALI, poudre pour suspension orale/rectaleFRESENIUS MEDICAL CARE NEPHROLOGICA DEUTSCHLAND
- CzechiaRESICALFresenius Medical Care Nephrologica Deutschland GmbH, Bad Homburg
- CanadaRESONIUM CALCIUMSANOFI-AVENTIS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Belgium · Kayexalate Calcium
- Czechia · Resical
- Germany · Elutit-Calcium
- Denmark · Resonium Calcium
- Estonia · Sorbisterit
- Spain · Resincalcio
- France · Resikali
- United Kingdom (Northern Ireland) · Calcium Polystyrene Sulfonate, Calcium Polystyrene Sulfonate Roma Pharmaceuticals
- Croatia · Xaviox
- Italy · Sorbisterit
- Luxembourg · Kayexalate Calcium
- Netherlands · Calciumpolystyreensulfonaat Focus Care, Sorbisterit
- Norway · Resonium-Calcium
- Poland · Calcium Resonium
- Portugal · Resical
- Slovakia · Calcium Resonium, Sorbisterit
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95944a29-5a6e-4bf0-9321-ce2fd577f293 GET /v1/drugs/95944a29-5a6e-4bf0-9321-ce2fd577f293?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral/rectal suspension",
"routes": [
"Oral use",
"Rectal use"
],
"source": "hpra",
"atc_all": [
"V03AE",
"V03AE01"
],
"strength": null,
"pa_number": "PA0540/141/001",
"substances": [
"Calcium polystyrene sulphonate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "01/04/1983",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about polystyrene sulfonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.